SOCS3 and colorectal carcinoma: Concerning Tumor microenvironment (TME) remodeling, a study reported that CRC metastatic cells release the pro-metastatic miR-181a-5p, which targets the Suppressor of cytokine signaling 3 (SOCS3) gene and activates STAT3-mediated-signaling [126].